RESEARCHER PROFILE

Celia J. A. Morgan

← Back to University of Exeter

C

University of Exeter

Neurotransmitter Receptor Influence on BehaviorSchizophrenia research and treatmentSubstance Abuse Treatment and OutcomesNeuroscience and Neuropharmacology ResearchTreatment of Major Depression

Celia J. A. Morgan works in Neurotransmitter Receptor Influence on Behavior, Schizophrenia research and treatment, Substance Abuse Treatment and Outcomes, Neuroscience and Neuropharmacology Research, Treatment of Major Depression. Recorded institutional associations include University of Exeter.

1,749Publications
10,349Citations
55H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Ketamine use: a review

    2011 · 655 citations
  2. Keep off the grass? Cannabis, cognition and addiction

    2016 · 389 citations
  3. Consequences of chronic ketamine self‐administration upon neurocognitive function and psychological wellbeing: a 1‐year longitudinal study

    2009 · 373 citations
  4. Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study

    2010 · 304 citations
  5. Acute and chronic effects of ketamine upon human memory: a review

    2006 · 302 citations
  6. Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis

    2008 · 299 citations
  7. Acute Effects of Ketamine on Memory Systems and Psychotic Symptoms in Healthy Volunteers

    2003 · 277 citations
  8. Journey through the K-hole: Phenomenological aspects of ketamine use

    2008 · 246 citations
  9. Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later

    2000 · 245 citations
  10. Dopaminergic Function in Cannabis Users and Its Relationship to Cannabis-Induced Psychotic Symptoms

    2013 · 215 citations
  11. Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial

    2020 · 203 citations
  12. Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis

    2010 · 195 citations
  13. Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being

    2011 · 194 citations
  14. Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings

    2013 · 193 citations
  15. Cannabidiol enhances consolidation of explicit fear extinction in humans

    2013 · 191 citations
  16. Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex‐users with polydrug and non‐using controls

    2008 · 187 citations
  17. Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review

    2021 · 186 citations
  18. Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users

    2014 · 183 citations
  19. The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level–Dependent Resting State Functional Connectivity

    2014 · 178 citations
  20. Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis ‘amotivational’ hypotheses

    2016 · 178 citations
  21. Adjunctive Ketamine With Relapse Prevention–Based Psychological Therapy in the Treatment of Alcohol Use Disorder

    2022 · 174 citations
  22. Ketamine for the treatment of addiction: Evidence and potential mechanisms

    2018 · 162 citations
  23. Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight

    2017 · 160 citations
  24. Just say ‘know’: how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?

    2014 · 140 citations
  25. Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function

    2018 · 140 citations

← Return to the university profile